GeneDx Holdings Corp at TD Cowen Healthcare Conference Transcript
Dan Brennan. TD Cowan, tools and diagnostics analyst, day one of the forty-sixth annual conference, pleased to be joined here with me on the stage, the management team of Gen DX to my immediate right, we have Catherine Stolin, who's, CEO, and her right we have, Kevin Feely, who's CFO. So Kevin, Katherine, thank you.
Thank you for having us.
Questions & Answers
Awesome. For sure. So. 25, another big year for GDX, really strong growth north of 40%, whole exim growth of over 50% with, 30% volume growth, good pricing gains. So, listen, you saw really strong growth from the foundational markets, but now entering 2026, you've really expanded the sales force pretty significantly to go after some new opportunities. So maybe just zooming out.
Just talk a little bit about like exiting 25, going into 26 with this kind of expanded
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
